Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NYSE:PFE
Tag: NYSE:PFE
Pfizer Inc. (NYSE:PFE) Phase II Clinical Trial Of Lorlatinib Shows Promise
-
October 17, 2017
0
Pfizer Inc. (NYSE:PFE) Lyrica CR Approved By FDA As Patent Expiry...
-
October 13, 2017
0
Pfizer, Inc. (NYSE:PFE) announces a quarterly dividend of $0.32
ME Staff
-
September 27, 2017
0
FDA Grants Eli Lilly and Co (NYSE:LLY) Baricitinib Faster Time Frame...
Andy Parker
-
August 31, 2017
0
Analyst Activity – Jefferies Group LLC Sets Its Price Target On...
ME Staff
-
August 2, 2017
0
Analyst Activity – Jefferies Group LLC Sets Its Price Target On...
ME Staff
-
August 2, 2017
0
GlaxoSmithKline plc (ADR)(NYSE:GSK) Axes More Than 30 Drug-Research Projects
Andy Parker
-
July 28, 2017
0
Analyst Downgrades – Pfizer (NYSE:PFE) Stock Gets Downgraded By Credit Suisse...
ME Staff
-
July 20, 2017
0
Analyst Downgrades – Pfizer (NYSE:PFE) Stock Gets Downgraded By Credit Suisse...
ME Staff
-
July 20, 2017
0
Biotech Movers: Johnson & Johnson (NYSE:JNJ) and Pfizer Inc. (NYSE:PFE)
-
July 17, 2017
0
1
2
3
4
...
11
Page 3 of 11
